Addressing the Risks of Respiratory Syncytial Virus for Patients With Inflammatory Bowel Disease in the Era of Novel Vaccines
- PMID: 37816231
- DOI: 10.1093/ibd/izad233
Addressing the Risks of Respiratory Syncytial Virus for Patients With Inflammatory Bowel Disease in the Era of Novel Vaccines
Erratum in
-
Correction to: Addressing the Risks of Respiratory Syncytial Virus for Patients With Inflammatory Bowel Disease in the Era of Novel Vaccines.Inflamm Bowel Dis. 2023 Dec 5;29(12):2014-2015. doi: 10.1093/ibd/izad271. Inflamm Bowel Dis. 2023. PMID: 38055773 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
